SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Nov 6, 2018
Document Date
Nov 6, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC